Lilly’s Tirzepatide Effective, But Tolerability Still A Limitation

Drug Reduces A1C, Weight In Diabetes

 
• By Alaric DeArment
  
Diabetes
Tolerability could remain a limitation for Lilly's tirzepatide despite positive Phase III efficacy data • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D